CBG and CBDV Could Revolutionize Alzheimer's and Parkinson's Treatment

Discover the neuroprotective potential of Cannabigerol (CBG) and Cannabidivarin (CBDV), two cannabinoids from the cannabis plant that could revolutionize the treatment of Alzheimer’s and Parkinson’s diseases. This video explores how CBG and CBDV interact with the brain's endocannabinoid system to reduce inflammation and oxidative stress, protecting brain cells from damage. Learn about the latest scientific studies supporting these findings and what this could mean for the future of neurodegenerative disease treatment.


Sources:

Western Sydney University Study (2022):

Title: "Therapeutic properties of multi-cannabinoid treatment strategies for Alzheimer’s disease"
URL: https://www.frontiersin.org/articles/...
University of Naples Federico II Study (2022):

Title: "In Vitro Model of Neuroinflammation: Efficacy of Cannabigerol, a Non-Psychoactive Cannabinoid"
URL: https://www.mdpi.com/1422-0067/19/7/1992
Scientific Reports Study:

Title: "Acute effects of cannabigerol on anxiety, stress, and mood: a double-blind, placebo-controlled, crossover, field trial"
URL: https://www.nature.com/articles/s4159...
Related Research on TRPV1 and Neuroprotection:

Title: "Targeting TRPV1 for Pain and Inflammation Reduction"
URL: https://www.ncbi.nlm.nih.gov/pmc/arti...